問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2014-07-10 - 2021-12-31
Condition/Disease
Test Drug
Participate Sites1Sites
Terminated1Sites
2015-09-03 - 2015-12-31
2016-06-01 - 2025-05-31
Triple Negative Locally Advanced Breast Cancer
atezolizumab (MPDL3280A)
Participate Sites7Sites
Terminated5Sites
Division of General Surgery
未分科
2015-12-10 - 2019-12-31
NON-SMALL CELL LUNG CANCER WHO HAVE BRAIN METASTASES
(1)Avastin; (2) Erlotinib
Participate Sites3Sites
Recruiting3Sites
2015-07-01 - 2016-12-31
2008-06-02 - 2009-12-31
2007-07-01 - 2009-12-31
2009-11-01 - 2012-12-31
2013-08-01 - 2015-05-31
Participate Sites5Sites
2013-07-01 - 2015-07-01
全部
